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Abstract
Background: Down syndrome (DS) individuals suffer mental retardation with further cognitive decline and early onset
Alzheimer’s disease.
Methodology/Principal Findings: To understand how trisomy 21 causes these neurological abnormalities we investigated
changes in gene expression networks combined with a systematic cell lineage analysis of adult neurogenesis using the
Ts1Cje mouse model of DS. We demonstrated down regulation of a number of key genes involved in proliferation and cell
cycle progression including Mcm7, Brca2, Prim1, Cenpo and Aurka in trisomic neurospheres. We found that trisomy did not
affect the number of adult neural stem cells but resulted in reduced numbers of neural progenitors and neuroblasts.
Analysis of differentiating adult Ts1Cje neural progenitors showed a severe reduction in numbers of neurons produced with
a tendency for less elaborate neurites, whilst the numbers of astrocytes was increased.
Conclusions/Significance: We have shown that trisomy affects a number of elements of adult neurogenesis likely to result
in a progressive pathogenesis and consequently providing the potential for the development of therapies to slow
progression of, or even ameliorate the neuronal deficits suffered by DS individuals.
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Introduction
Down syndrome (DS) is a result of trisomy or partial trisomy of
human chromosome 21 (HSA21) and has an incidence of 1 in
approximately 1000 live births [1]. Individuals are affected by a
large number of abnormalities that vary in gravity and involve
most organ systems. The foremost and most debilitating trait of
DS is mental retardation, which ranges from mild to severe and is
followed by a loss of cognitive abilities in adulthood and the
development of early onset Alzheimer’s disease (AD) [2,3,4]. How
trisomy 21 results in cognitive impairment remains unclear,
however, associated structural brain abnormalities have been
described. The DS brain is characterised by a reduction in overall
size and a disproportionate reduction in size of particular regions
due to hypocellularity. These regions include the hippo-
campal dentate gyrus and cerebellum in the pre-natal brain and
the cerebral hemispheres, frontal lobe, hippocampus and
cerebellum in the postnatal brain [5,6,7,8,9,10,11,12,13,14,15].
Other neural abnormalities identified include altered cortical
lamination and consistent dendritic and synaptic abnormalities
[16,17,18,19,20,21,22,23,24]. The neuropathological marks of AD
(neuritic plaques containing amyloid b surrounded by degenerat-
ing nerve terminals and neurofibrillary tangles composed of
aggregated hyperphosphorylated tau) are present in essentially all
adult DS brains, however, it seems that not all individuals develop
clinically recognised AD [25].
We utilised a mouse model to investigate how trisomy 21 might
affect gene regulatory networks and adult neurogenesis. Mouse
chromosome 16 (MMU16) has significant homology with HSA21
[26]. A number of mice trisomic for large segments of MMU16 or
HSA21 (for summary see Text S1) or trisomic for single HSA21
genes have been created. The development of three models in
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Ts1Cje) for MMU16 has greatly facilitated investigations of the
central nervous system [26,27,28]. Despite showing some
similarities to DS, the trisomic chromosome carried by Ts16
contains genes not orthologous to HSA21, furthermore these mice
die in utero precluding analysis of the postnatal consequences of
trisomy [29,30,31].
A number of features analogous to DS have been demon-
fstrated in the partially trisomic mouse models and the extent
and severity of the phenotypes observed mostly correlate with the
size of the trisomic segment. Both Ts65Dn and Ts1Cje mice
display craniofacial dysmorphology that directly parallels
human DS and defective spatial learning and memory
[32,33,34,35,36,37,38,39,40]. Abnormalities in physical structure
of particular areas of the brain also seen in human DS have been
demonstrated in the Ts65Dn and Ts1Cje models, which include
hypocellularity in hippocampal structures including the dentate
gyrus in Ts65Dn mice [41]. Furthermore, it has been shown that
there is a progressive degeneration and loss of cholinergic neurons,
which are particularly vulnerable in AD, in the basal forebrain of
Ts65Dn [42,43].
Proliferation defects have been demonstrated in the hippocam-
pal dentate gyrus and neocortical germinal matrix of DS, Ts16
and Ts65Dn foetuses, postnatal Ts65Dn mice and in the
hippocampal dentate gyrus and cerebellum of adult Ts65Dn mice
[41,44,45,46,47,48,49,50,51,52,53]. More recently, impaired neu-
rogenesis has been described in the hippocampal dentate gyrus
and the subventricular zone (SVZ) of the lateral ventricles of adult
Ts1Cje and Ts2Cje (genetic equivalent of Ts65Dn) mice and also
in the embryonic cortex of both models [54]. Additionally, a
reduction in proliferation of neurospheres isolated from the
neocortex of Ts1Cje embryos has also been depicted recently [55].
Neurogenesis occurs prenatally and postnatally but also
throughout adulthood, the latter in predominantly two regions
of the brain, the subgranular zone of the dentate gyrus and the
SVZ lining the lateral ventricles. Neural stem cells (NSCs) residing
in neurogenic regions have the ability to self-renew and
differentiate into neurons, astrocytes and oligodendrocytes
[56,57]. They give rise to transit amplifying neural progenitors
and subsequently to neuroblasts with limited proliferative capacity.
Neuroblasts in turn differentiate into neurons. Newly formed cells
in the SVZ migrate rostrally along the lateral walls of the lateral
ventricles forming the rostral migratory stream (RMS) to the
olfactory bulbs where they become interneurons [58,59,60].
Based on a number of in vivo and ex vivo experiments we show that
Ts1Cje adult neurogenesis is reduced as a result of abnormal
progenitor production and defects in cell lineage commitment during
differentiation rather than defects in NSC development or homeo-
stasis. Moreover, we identified specific regulators of cell cycle
progression that are dysregulated in neural precursors isolated from
the adult Ts1Cje SVZ. We hypothesise that these defects in adult
neurogenesis confound pre-existing developmental defects and are
likely to progressively contribute to problems in memory formation
and possibly brain functions throughout adult life. We also expect
that the defects will impair the ability of the DS brain to respond to
neuronal loss and degeneration with repair.
Results
Genes involved in proliferation are disrupted in Ts1Cje
adult neurospheres
In order to identify genes dysregulated in adult Ts1Cje
neurogenesis we performed a whole-genome expression analysis
using GeneChipH Mouse Genome 430 2.0 Arrays (Affymetrix,
Santa Clara, USA) on 3 pairs of female Ts1Cje and disomic
littermate control primary neural stem and progenitor cells after
expansion for 7 days as neurosphere cultures. This data is freely
accessible on the Gene Expression Omnibus website under the
series accession number GSE17760.
To examine the overall behaviour of genes in the trisomic
region, we plotted the log2 fold-changes (M) for trisomic versus
disomic mice versus the average log2 expression (A). Each dot
represents a single probe. Probes that were not expressed naturally
did not show any change, i.e., the log2 fold-changes were around
0, but probes that were expressed at worthwhile levels (A-values
.5) consistently showed fold changes of around 1.5 (equivalent to
M value ,0.58; Figure 1). Our data therefore supports the gene
dosage effect hypothesis, which specifies that three copies of the
majority of the genes involved in DS results in an increase in their
expression of 50%.
Figure1.MA plotsofMMU16trisomicanddisomicmicroarrayprobessupportthegenedosageeffecthypothesis.Mis the average log2fold
changeinintensityoffluorescenceinthetrisomiccomparedtothedisomic(asacontrol).Ais the average log2intensity of fluorescencefor bothgenotypes.
The majority of expressed probes to genes located in the trisomic region had an M value of ,0.58= fold change ,1.5 (marked by a black dashed line),
compared to the majority of disomic probes which have an M value of 0= fold change 1. The red dashed line is the line of loess fit to the M values.
doi:10.1371/journal.pone.0011561.g001
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no great changes in gene expression outside of the trisomic region
are expected, which is what we observed in the gene expression
profile of the Ts1Cje neurospheres. A global analysis of the P-
values suggested that around 6.5% of expressed probes (2052
probes) may be differentially expressed, although the fold changes
were small so that few genes could be individually identified as
differentially expressed at conventional significance levels. In order
to uncover changes in groups of functionally interconnected genes
we utilised two online analysis tools the Database for Innovation,
Visualization and Integrated Discovery (DAVID; [61] and
Ingenuity Pathway Analysis (IPA).
Intriguingly, the DAVID and IPA analyses highlighted that a
significant number of genes that were differentially expressed were
involved in proliferation with roles in cell cycle control, DNA
replication, recombination and repair and chromosomal modifi-
cations (Table S1 and Figure 2). The majority of these genes were
downregulated and disomic. Functional annotation of the probes
that were over expressed in the Ts1Cje neuropsheres identified a
significant enrichment associated with genes that are involved in
general cellular functions including energy production, metabo-
lism and endocytosis, suggesting that the cells may be under some
degree of stress (Table S1).
Focusing on the IPA network with the largest number of
differentially expressed probes (Figure 2) we analysed the
expression of 11 genes (Aurka, Brca2, Ccnb1, Ccna2, Cenpo, Itsn1
(trisomic), Mcm7, Pbk, Phb, Prim1 and Suv39h1) by RT-qPCR in
neurosphere cultures generated from 3 pairs of female Ts1Cje and
disomic littermate controls independently of the original micro-
array analysis (Figure 3 and Table S2). Similar to the array results,
the differences in expression between the genotypes were small but
consistent. The direction of differential expression was validated in
10/11 genes. Itsn1, the trisomic gene was upregulated in the
Ts1Cje neurospheres as expected. All genes that were downreg-
ulated in the Ts1Cje neurospheres by microarray analysis were
also downregulated by RT-qPCR (Aurka, Brca2, Ccnb1, Ccna2,
Cenpo, Mcm7, Pbk, Prim1 and Suv39h1). Phb was shown to be slightly
downregulated in the Ts1Cje neurospheres by RT-qPCR analysis
but upregulated in the microarray analysis.
To examine whether these small abnormalities in gene
expression affect the Ts1Cje brain we examined the neurogenic
lineage systematically from neural stem cells (NSCs) through
neural progenitors, via neuroblasts, to neuronal differentiation and
neurite outgrowth. In addition, we also examined neuroblast
migration.
Normal numbers of neural stem cells in Ts1Cje in vivo
Gene expression abnormalities in proliferation associated genes
imply that there are defects in the proliferation of trisomic NSCs
and/or progenitors. We used a double labelling assay with the
thymidine analogues 5-chloro-29-deoxyuridine (CldU) and 5-iodo-
29-deoxyuridine (IdU) to investigate whether there is a reduction in
the numbers of NSCs or a defect in the proliferation of NSCs in
the adult Ts1Cje subventricular zone (SVZ). Thymidine analogues
are incorporated into DNA during the DNA synthesis phase of the
cell cycle and then diluted exponentially following cell division
when half the analogue is distributed to the daughter cell. The
thymidine analogue is undetectable by immunohistochemistry
after 3 cell divisions.
NSCs are relatively quiescent with a relatively long cell cycle
length of ,15 days and an S phase of ,8 h [62,63]. In
comparison, the proliferating proportion of the SVZ population
of cells have an estimated cell cycle length of ,12.7 h and an S
phase of ,4.2 h [64]. To investigate the thymidine analogue label
retention of NSCs we injected 4 pairs of male Ts1Cje and disomic
mice twice daily for 7 days with IdU, left them without treatment
for 7 days, injected them twice daily with CldU for 7 days and then
left them without treatment for 7 days. Based on the reported
duration of cell cycles, S phases and thymidine analogue
bioavailability of 2 h this labelling treatment strategy should label
only NSCs as the thymidine label in neural progenitors will be
diluted to levels below detection through a high number of cell
divisions [65]. Neuroblasts that were in their last cycle division
during thymidine labelling will have migrated away from the
neurogenic zone to the olfactory bulbs.
IdU positive cells were counted in the subventricular neurogenic
zone at 5 equally spaced rostrocaudal levels. We found no
significant difference in the number of IdU long-term label
retaining cells (P=0.053; N=4 pairs of male Ts1Cje and disomic
controls; Figure 4), or double label (IdU and CldU) retaining cells
(P=0.97; N=4 pairs of male Ts1Cje and disomic controls; data
not shown). We therefore detected no difference in the number of
NSCs in the adult Ts1Cje brain compared to their sex matched
disomic littermate controls.
Normal numbers of apoptotic cells in the Ts1Cje
subventricular zone
We examined the incidence of cell death using the TUNEL
assay. We found that there was no difference in the numbers of
apoptotic cells in the SVZ between Ts1Cje and disomic mice
demonstrating that the disruption in genes involved in
proliferation have no affect on the rate of cell death
(P=0.767; N=2 pairs of female and 2 pairs of male Ts1Cje
and disomic controls; Figure 5). Given that our in vivo assay
showed no difference in the number of NSCs in the Ts1Cje
SVZ, we used an ex vivo assay to examine the self-renewal ability
of adult NSCs and progenitors.
Reduced number of neural progenitors in the Ts1Cje
subventricular zone
Adult NSCs and progenitors can be grown in proliferation
medium containing EGF and FGF2 as floating colonies of cells or
neurospheres [56,66]. We utilised this characteristic to assess the
ability of Ts1Cje adult NSCs and progenitors to give rise to
colonies of undifferentiated cells. The number of neurospheres
derived from the SVZ of Ts1Cje mice was consistently reduced,
with an average 28% reduction compared to sex matched disomic
littermate controls (P=0.0099; N=4 pairs of female and 4 pairs of
male Ts1Cje and disomic controls; Figure 6A and B).
Since we found no difference in the number of long-term label
retaining NSCs and the self-renewal ability of the stem cells is
sufficient to maintain NSC numbers, the reduction in Ts1Cje
neurosphere formation is most likely due to a reduced production
of neural progenitor cells from NSCs. We subsequently examined
whether the number of Ts1Cje neuroblasts was also reduced.
Reduced numbers of migrating neuroblasts in the Ts1Cje
rostral migratory stream
We quantified the size of the neuroblast population generated
by the SVZs of Ts1Cje and disomic sex matched littermate
controls. Neuroblasts express the cell surface molecule polysialic
acid-neural cell adhesion molecule (PSA-NCAM) and move as
chains of migrating neuroblasts from the SVZ to the olfactory
bulbs where they become periglomerular and granule cell
interneurons [58,59,60]. Migratory neuroblasts across the lateral
walls of the lateral ventricles were labelled with an anti PSA-
NCAM antibody, traced and quantified. In comparison to sex
Ts1Cje Neurogenesis Defects
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number of migratory neurons in Ts1Cje with an average of 18%
(P=0.003; N=5 pairs of sex matched Ts1Cje and disomic
littermate controls; Figure 7). Furthermore, through measurement
of histological landmarks we show that the anterior-posterior
length of the Ts1Cje olfactory bulbs are shorter than their disomic
littermate controls (P=0.0005; N=5 pairs of sex matched Ts1Cje
and disomic littermate controls; Figure 7).
The PSA-NCAM staining revealed that the Ts1Cje neuroblasts
were reduced in number, but directional pattern of migration
appeared normal and there was no obvious defects such as
blockages or altered orientation. In the following experiment we
Figure 2. Gene network analysis of microarray data. IPA network containing the largest number of connected differentially expressed probes
(cut off t-statistic 64) from a comparison of 3 pairs of female Ts1Cje and disomic littermate control neurosphere cultures constructed from microarray
expression data. The top functions associated with these probes include cell proliferation, DNA replication, recombination and repair, cell cycle and
cancer. Green symbols represent probes that were downregulated in Ts1Cje neurospheres compared to disomic neurospheres, whilst red symbols
represent probes that were upregulated in Ts1Cje neurospheres. Grey symbols represent connected probes that where unchanged in Ts1Cje
neurospheres.
doi:10.1371/journal.pone.0011561.g002
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analogue labelling assay.
Tendency for the migration of Ts1Cje neuroblasts to be
delayed
Neuroblasts take between 2 and 6 days to migrate from the
SVZ to the olfactory bulbs via the RMS [58]. Mice were injected
with the thymidine analogue 5-bromo-29deoxyuridine (BrdU)
twice daily for 4 days and left without treatment for 2 days. The
migration front of the neuroblasts was identified in serial brain
sections through positive staining for BrdU (Figure 8A).
Following identification of the migratory front in the olfactory
bulbs the distance from the frontal cortex to the migration front
was measured (Figure 8B). In each pair of mice the disomic
neuroblasts had migrated further into the olfactory bulbs. On
average the labelled neuroblasts had migrated 247.5 mmf u r t h e r
into the olfactory bulbs of disomic mice compared to Ts1Cje
mice, however the difference was just below the level of
significance due to large variations between animals (P=0.056;
N=3 male and 1 female pairs of Ts1Cje and disomic
littermates).
Finally, we examined the ultimate product of SVZ neurogen-
esis, the differentiating neuron.
Reduced numbers of neurons arise from Ts1Cje neural
progenitors
Removal of the growth mitogens EGF and FGF2 from
neurosphere medium and addition of 1% foetal calf serum results
in differentiation of NSCs and progenitors [56]. To determine
whether Ts1Cje NSCs have a defect in neuronal differentiation we
compared the number of neurons, astrocytes and oligodendrocytes
produced by Ts1Cje and sex matched disomic littermate neuro-
sphere cells in vitro. Following 7 days of primary culture,
neurospheres were dissociated and plated onto poly-ornithine
and laminin coated coverslips. Cell types were identified by
immunofluorescence using antibodies against type III b-tubulin,
glial fibrillary astrocyte protein (GFAP) and O4 to mark neurons,
astrocytes and oligodendrocytes respectively. The number of
neurons generated from Ts1Cje neurospheres was reduced with
an average of 56% compared to sex matched disomic littermate
controls (P=3.987e-06; N=4 pairs of adult female Ts1Cje and
disomic littermate controls; Figure 9A). In contrast and corre-
spondingly, the number of astrocytes generated from Ts1Cje
neurosphere cells was increased by an average of 6% (P=2.632e-
05; N=4 pairs of adult female Ts1Cje and disomic littermate
controls; Figure 9B). There was no difference between the
numbers of oligodendrocytes and unclassified cells produced by
the Ts1Cje and disomic littermate control neurosphere cells (data
not shown).
Differentiated Ts1cje neurons have a tendency for
reduced side branching
Examination of the neurons that were produced by both
genotypes showed that there was no difference in the number of
primary neurites per cell (P=0.66) or the average length (P=0.55)
of primary neurite (Figure 10A and B). The number of Ts1Cje
neurons with a secondary or tertiary neurite was consistently lower
than the number of disomic neurons. While the difference was not
significantly statistically different (secondary neurite P=0.079;
tertiary neurite P=0.141; N=4 female Ts1Cje and sex matched
disomic littermate controls; Figure 10C), lower neurite complexity
has been observed in human DS and trisomic mice
[67,68,69,70,71]. There was no difference in the average length
of Ts1Cje and disomic secondary (P=0.97) or tertiary (P=0.96)
neurites (Figure 10D).
Figure 3. RT-qPCR and microarray neurosphere data for 11 selected proliferation associated genes. Microarray M values compared to
the RT-qPCR Ts1Cje vs disomic log2 fold changes in expression normalised to the disomic neurospheres. RT-qPCR and microarray analysis were
completed on 3 independent pairs of female 7-day-old Ts1Cje and disomic littermate control neurospheres. Both microarray and RT-qPCR differential
expression was assessed using empirical Bayes moderated t-statistics [98] calculated using the limma package [100] and adjusted for multiple testing
[99]. The trisomic gene Itsn1 was upregulated in both the microarray and RT-qPCR data. All genes that were downregulated in the Ts1Cje compared
to the disomic neurospheres by microarray analysis were also downregulated by RT-qPCR (Aurka, Brca2, Ccna2, Ccnb1, Cenpo, Mcm7, Pbk, Prim1 and
Suv39h1). Phb was upregulated in the Ts1Cje neurospheres by microarray analysis, but slightly downregulated by RT-qPCR.
doi:10.1371/journal.pone.0011561.g003
Ts1Cje Neurogenesis Defects
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We have used a combination of in vivo and ex vivo assays, a gene
expression and network analysis to understand a number of
aspects of adult neurogenesis in the Ts1Cje mouse model of DS.
We have distinguished for the first time that reductions in cell
numbers observed by others are due to reductions in neural
progenitors and neuroblasts rather than NSCs in the Ts1Cje
subventricular zone (SVZ). In this study we also observed
dysregulated expression of genes involved in proliferation,
particularly cell cycle control. We have shown a tendency for
delayed neuroblast migration through the adult Ts1Cje SVZ.
Importantly, we have uncovered severe defects in Ts1Cje neural
differentiation, in particular a reduction in the production of
neurons and a tendency for reduced side branching. Given that
our work demonstrates neurogenesis defects exist during adult-
hood suggests that there is potential to slow aspects of the
progression of cognitive decline and neurodegeneration in DS.
Analysis of our microarray expression data from adult SVZ
neurosphere cultures using both the Database for Innovation,
Visualisation and Integrated Discovery (DAVID) and Ingenuity
Pathway Analysis (IPA) identified dysregulation of genes involved
in proliferation in Ts1Cje samples. The majority of proliferation
associated genes showing disrupted expression were subtly
downregulated and not from the Ts1Cje trisomic region,
indicating that trisomy results in a large number of downstream
gene expression abnormalities that combined would affect
proliferation in adult neural progenitors. The largest IPA network
of differentially expressed genes included a number of genes whose
down regulation could delay cell cycle progression. The following
discussion is focused around the genes from this network for which
expression was most affected by trisomy. The helicase mini-
chromosome maintenance proteins (MCMs) and Prim1 (small
subunit of primase, which synthesises oligoribonucleotides that act
as primers for initiation of DNA synthesis) are involved in DNA
replication and their reduced expression is likely to result in a
delay or elongation of the S phase of the cell cycle [72,73,74].
Brca2 has various roles in the maintenance of genome stability, but
its main function appears to involve the regulation of the function
of Rad51 (DNA repair protein) during DNA repair by
homologous recombination. Homologous recombination is the
predominant mechanism of repair for double strand breaks during
the S-phase and G2-phase of the cell cycle and Brca2 deficiency
has been shown to impair cytokinesis and extend cell division
[75,76]. The CENP-H/I multiplex kinetochore complex, contain-
ing the centromere protein O (CENP-O; interphase centromere
complex protein 36) has been shown to be required for proper
chromosome alignment and segregation in chicken and human
cells [77]. Furthermore, it has been demonstrated that CENP-O
deficient cells had a lengthened G2/M phase [77]. Aurka is a
member of a family of serine/threonine kinases and plays a critical
role in mitosis. It is necessary for formation of mitotic spindles,
separation of the centrosomes after the mitotic spindle has been
formed and ensures correct organization and alignment of
chromosomes during prometaphase [78,79]. Therefore, its
downregulation may prevent or slow exit from mitosis.
Based on the changes in gene expression that we observed we
would expect a delay in cell cycle progression in the S or G2 and
M phases. Indeed, elongation of the G1 but particularly the G2
phase has been observed in trisomic neural precursors [44,47,48].
Interestingly, it has been demonstrated that the expression of
Ccnb1 and Skp2, two key regulators of the G2/M and G1/S
transitions are decreased in neonatal (PN2) Ts65Dn cerebellar
granule cell precursors [47]. While these observations have been
made in a different area of the brain and during development
rather than in the adult, they support our data and suggest that
delays in cell cycle transitions particularly the G2/M phase may be
a common theme in trisomic cell division. Notably, we found
Ccnb1 to be downregulated in adult neurospheres. Furthermore, all
probes located to the Skp loci on our microarray that were
expressed in adult neurospheres were reduced in the Ts1Cje
compared to disomic controls, with fold changes ranging from
0.64 to 0.87.
A recent gene expression study on embryonic neural progenitors
cultured as neurospheres from the E14.5 Ts1Cje neocortex also
observed dysregulation of genes involved in proliferation, although
changes in expression of individual genes differed from our study
[55]. These differences are likely to be due to a number of factors
including the different age of mice that the neural progenitors were
Figure 4. Trisomic neurogenic SVZ contain normal numbers of
label retaining cells. (A) Immunofluorescence detection of typical IdU
long-term retaining cells (marked by arrows), labelled with an anti-BrdU
antibody, which also detected IdU but not CldU (clone B44, BD
Biosciences; green) and DAPI nuclear counterstain (blue). Original
magnification 6400. Scale bar =10 mm. (B) There was no difference in
the number of IdU long-term retaining cells in the SVZ of Ts1Cje and
disomic sex matched controls (P=0.053; N=4 pairs of male Ts1Cje and
disomic littermate controls). The number of IdU retaining cells were
counted at 5 equally spaced rostrocaudal levels. (C) Neural cell lineage
schematic with the cell type examined highlighted – NSC, neural stem
cell. Other cells: TA, transit amplifying cell; Nb, neuroblast; N, neuron;
GP, glial precursor; A, astrocyte; O, oligodendrocyte.
doi:10.1371/journal.pone.0011561.g004
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number of passages carried out prior to RNA extraction. Moldrich
et al., (2009) used cells after at least four passages in culture, whilst
we subjected cells to only one passage in culture before conducting
the microarrays. We note that we have shown changes in gene
expression in trisomic neural precursors even in different pathways
to those observed by others despite some similarities in neural
differentiation defects [80,81]. In particular, we observed no
deregulation in the expression of the neuron-restrictive silence
factor (REST-repressor element-1 silencing transcription factor) or
Rest regulated genes in the trisomic neural progenitor cells. This
could be due to the differences in the source of cells investigated.
We used primary neurospheres, whilst Bahn et al., (2002) analysed
cells after more than 10 weeks of culture and Canzonetta et al.,
(2008) analysed cell lines following at least 3 passages. In this
context it is important to note that striking differences have been
observed between primary neuronal cells and cells cultured for
extended periods such that primary cells are expected to reflect the
situation in vivo more accurately [82,83,84].
To our knowledge, no previous study has differentiated between
the effects of trisomy 21 in humans, or 16 in mice on NSCs versus
neural progenitor cells. We did not detect a difference between the
number of adult Ts1Cje and disomic control NSCs in vivo using a
double thymidine analogue labelling assay. However, we observed
a reduction in stem cell/progenitor derived primary neurospheres
from the Ts1Cje SVZ and neuroblasts migrating through the
RMS. A partial block in the S, G2 or M phases of the cell cycle
could explain a low production of neural progenitors and
neuroblasts. In concordance with previous findings and a
reduction in the numbers of neural progenitors and neuroblasts
the anterior-posterior length of the Ts1Cje olfactory bulbs were
shorter than the disomic controls [54].
In support of our findings others have reported similar defects in
the production of neural progenitors, albeit the majority of studies
have been focused on different areas of the brain, at different
stages of development. A number of studies of Ts16, Ts65Dn and
DS embryonic brain development have identified cell cycle and
neurogenesis abnormalities in the neocortex and hippocampus
[44,45,49,50,51]. A substantial delay in prenatal growth of the
Ts65Dn cortex and hippocampus was shown to be due to a longer
cell cycle and reduced neurogenesis from the ventricular zone
neural precursor population [44]. Correspondingly, reduction in
the number of proliferating cells in the germinal zones of DS foetal
hippocampus, parahippocampus and lateral ventricles has been
demonstrated [48,49]. Similarly, reduced cell proliferation has
been demonstrated in the neocortical germinal matrix of human
DS foetuses and the dentate gyrus of postnatal day 2 (PN2) and 6
Ts65Dn mice [41,48]. Of the cells that were dividing in the DS
foetal neocortex and Ts65Dn PN2 dentate gyrus, a higher
proportion were in the G2 phase, which was also shown to be
prolonged compared to the disomic [48]. Additionally, a reduction
in the proliferative capacity due to increased cell cycle duration of
neural progenitors cultured from embryonic neocortical Ts1Cje
neurospheres has been described [55]. It has been demonstrated
that postnatal development of the hippocampus is affected by
abnormal proliferation in the subgranule zone [47,48,52].
Reduced proliferative capacity of the adult neural stem cell
(NSC) population of the hippocampus has been shown in both
young and old adult Ts65Dn mice [46,53]. Recently, a reduction
in the number of neuroblasts in the SVZ and a reduction in the
number of proliferating cells was demonstrated in the SVZ of the
lateral ventricles and dentate gyrus of adult Ts2Cje (genetically
equivalent to Ts65Dn) and Ts1Cje [54]. The same authors also
reported reduced cortical neurogenesis in the embryo of both
mouse models.
Our neurosphere data imply that there is a major reduction in
the capacity of Ts1Cje neural progenitors to differentiate into
neurons by more than 50%. The number of neurons produced by
the SVZ has not been assessed previously in models of DS. Defects
in neural differentiation have been reported for other areas of
trisomic brains and recently a greater number of GFAP-positive
cells were observed prior to differentiation in neural progenitors
isolated from the E14.5 Ts1Cje neocortex [46,47,48,49,55]. It has
been suggested that the smaller number of neurons is attributable
to the fact that precursors proliferate at a slower rate rather than,
or in addition to, impaired differentiation. However, as our data of
neuronal differentiation is based on equal numbers of neural
progenitors, we observed a greater than 50% reduction in neurons
produced and a compensating increase in astrocytes, we conclude
that trisomic neural progenitors differentiate into astrocytes at the
expense of neurons. This phenomenon constitutes a disturbance in
cell lineage commitment and differentiation that cannot be
Figure 5. Assessment of cell death by apoptosis. There was no difference in the number of apoptotic cells in the SVZ of Ts1Cje and disomic sex
matched controls (P=0.767; N=4 pairs of sex matched Ts1Cje and disomic littermate controls). Apoptotic cells were detected by TUNEL assay and
counted at 5 equally spaced rostrocaudal levels.
doi:10.1371/journal.pone.0011561.g005
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observed.
We have demonstrated that the expression of a number of genes
involved in control of the cell cycle are disrupted and that there are
a number of abnormalities in adult Ts1Cje adult neurogenesis,
however the question remains, which trisomic gene or genes are
responsible? It is tempting to speculate that the abnormalities we
have observed are due to the overexpression of the dual-specificity
tyrosine-(Y)-phosphorylation regulated kinase 1A gene (Dyrk1A),
which is located on the Ts1Cje trisomic region. Indeed, the 3
Dyrk1A probes on our microarray were overexpressed at expected
trisomic levels. Dyrk1A has been shown to have a highly dynamic
expression pattern throughout mouse brain development sugges-
tive of a key role in regulating the multiple events that occur
during neuronal development [85]. Expression during the S- and
G2-phases of the neuronal progenitor cell cycle combined with the
altered levels of cell cycle regulators found in mice overexpressing
Dyrk1A and the phosphorylation of cell cycle regulators by
DYRK1A led to the suggestion that it is a regulator of neural
progenitor proliferation [85,86,87]. Dyrk1A is also co-expressed
transiently in newborn neurons with high levels of p27
KIP1, which
has been shown to be involved in neuronal differentiation
[85,88,89]. Transgenic mice overexpressing human or mouse
Dyrk1A have been generated and were shown to display
hippocampal-dependent spatial learning and memory defects,
developmental delay and motor deficits [90]. Interestingly, it was
recently shown that using shRNA to inhibit Dyrk1A in the striatum
of a transgenic mouse model of Dyrk1A resulted in the restoration
of motor coordination, attenuation of hyperactivity and improve-
ment of sensorimotor gating [91].
Our data demonstrate the presence of neurogenesis defects in
the adult trisomic brain at multiple levels in the neurogenic
lineage, which we suggest will increase the vulnerability of DS
neurons for neurodegeneration. We also hypothesise that the
existence of adult nuerogenesis defects in the trisomic brain may
offer the opportunity to develop therapies that might either slow
down the progression or even improve the neuronal deficits. A
number of recent studies have provided evidence to suggest that
this is not an unreasonable suggestion, proposing that a number of
agents can improve learning and memory and possibly even brain
structure in the adult Ts65Dn mouse [92,93,94,95].
In conclusion, we have investigated the characteristics of adult
neurogenesis in the Ts1Cje brain and determined that; 1)
Neurogenic cells isolated from the adult Ts1Cje brain exhibited
disrupted expression of genes encoding proteins involved in cell
cycle progression. 2) Ts1Cje brains had normal numbers of long-
term retaining NSCs. 3) In contrast, the numbers of self-renewing
neural progenitor colonies, were reduced. 4) There was a
reduction in the number of neuroblasts migrating through the
Ts1Cje RMS compared to disomic controls. 5) Our data suggests
that the speed of adult Ts1Cje neuroblasts migration was reduced.
6) The number of neurons produced by adult Ts1Cje neurogenic
progenitors showed a striking reduction to less than one half whilst
the numbers of astrocytes was increased. 7) Ts1Cje neurons
showed a tendency for less elaborate neurites.
Materials and Methods
Ethics Statement
All breeding and experiments were approved by the Walter and
Eliza Hall Institute Animal Ethics Committee (Project numbers
2001.45, 2004.041 and 2007.007).
Animals
Sex matched disomic littermates were used as controls for all
experiments. All mice were aged to 3 months (84 days). Ts1Cje
and disomic mice were generated by mating Ts1Cje males
(originally obtained from The Jackson Laboratory, Bar Harbour,
USA) with C57BL/6 female mice for over 10 generations.
Offspring were genotyped using multiplex PCR primers for
neomycin and App (as an internal control) as described previously
[28] substituting gel electrophoresis with high resolution melting
analysis [96].
Microarray analysis
RNA was extracted from 3 Ts1Cje and 3 disomic female
littermate control neurospheres (generated from adult subventri-
cular zone (SVZ) cells) cultured for 7 days after isolation using a
Qiagen RNeasy micro kit (Qiagen, Hilden, Germany) according
to the manufacturer’s instructions with the DNase I digestion step.
Figure 6. Trisomic SVZ contains fewer colony-forming cells. (A)
Typical Ts1Cje and disomic neurosphere cultures. Original magnification
620 Scale bar =100 mm. (B) The number of neurospheres derived from
the SVZ of Ts1Cje mice was reduced compared to disomic sex matched
littermate controls in both males and females (P=0.0099; N=4 pairs of
female and 4 pairs of male Ts1Cje and disomic controls). (C) Neural cell
lineage schematic with the cell type examined highlighted – TA, transit
amplifying cell. Other cells: NSC, neural stem cell; Nb, neuroblast; N,
neuron; GP, glial precursor; A, astrocyte; O, oligodendrocyte.
doi:10.1371/journal.pone.0011561.g006
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PLoS ONE | www.plosone.org 8 July 2010 | Volume 5 | Issue 7 | e11561Figure 7. The Trisomic SVZ contains fewer migrating neuroblasts. (A) Whole mount immunohistochemistry of the lateral walls of the lateral
ventricles of a typical adult Ts1Cje and disomic sex matched littermate pair, stained with an antibody against PSA-NCAM and the staining traced to
allow quantification. (B) The traces of migratory neurons within the Ts1Cje RMS were reduced by an average of 18% compared to disomic controls
(P=0.003; N=5 pairs of sex matched Ts1Cje and disomic littermate controls). (C) Measured using histological landmarks within the olfactory bulb, the
anterior-posterior length of the Ts1Cje olfactory bulbs were reduced compared to disomic controls (P=0.0005; N=5 pairs of sex matched Ts1Cje and
disomic littermate controls). (D) Neural cell lineage schematic with the cell type examined highlighted – Nb, neuroblast. Other cells: NSC, neural stem
cell; TA, transit amplifying cell; N, neuron; GP, glial precursor; A, astrocyte; O, oligodendrocyte.
doi:10.1371/journal.pone.0011561.g007
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Bioanalyzer (Agilent Technologies, Santa Clara, USA). Each RNA
sample was processed using the Two-Cycle Target Labelling Assay
and hybridised onto an Affymetrix GeneChipH Mouse Genome
430 2.0 Arrays according to the manufacturer’s instructions
(Affymetrix, Santa Clara, USA). Fluorescent signals were detected
using a GeneChipH Scanner 3000 (Affymetrix, Santa Clara, USA).
Expression data were pre-processed and normalized using the
gcRMA algorithm [97]. Differential expression was assessed using
empirical Bayes moderated t-statistics [98] and P-values were
adjusted for multiple testing [99] using the limma package and R
statistical software (www.r-project.org) [100]. An additional global
analysis of the P-values was completed to estimate the true
percentage of statistically significantly expressed genes [101]. The
online analysis tools The Database for Annotation, Visualization
and Integrated Discovery (DAVID; [61] and Ingenuity Pathway
Analysis (IPA; from Ingenuity Systems Inc., Redwood City, USA;
http://www.ingenuity.com) were used to uncover changes in
functionally interconnected genes from a list of the most
differentially expressed genes (Further description in Text S1).
Using a t-statistic value of 4 as a cut off, probes that were over or
underexpressed in the Ts1Cje neurospheres compared to disomic
neurospheres were selected for analysis.
Quantitative real time polymerase chain reaction
(RT-qPCR)
RT-qPCR was used to validate the expression of 11 selected
genes from the microarray analysis. RNA was extracted
independently from the microarray samples from 3 female Ts1Cje
and 3 disomic litermate control 7-day-old neurosphere culture
pellets using a Qiagen RNeasy micro kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions with the
DNase digestion step. RNA quality and quantity was assessed
using a 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
USA). First strand cDNA was synthesised using random hexamers
and the SuperScript
TMIII Reverse Transcriptase Kit (Invitrogen,
Carlsbad, USA) according to the manufacturer’s instructions.
Primers were designed and probes selected using ProbeFinder
Version 2.34 (Universal ProbeLibrary Assay Design Center,
Roche Applied Science https://www.roche-applied-science.com).
Primer and probe sequences are detailed in the Text S1. RT-
qPCR was performed in triplicate on 330 ng total RNA template
with 1X LC480 Master Probe Mix (Roche Diagnostics, Basel,
Switzerland), 250 nM forward and reverse primers (GeneWorks,
Thebarton, Australia), 100 mM Universal ProbeLibrary probe
(Roche Diagnostics, Thebarton, Australia) made to a final volume
of 10 ml with PCR-grade H2O (Roche Diagnostics, Thebarton,
Australia), on a LightCyclerH 480 System (Roche Diagnostics,
Thebarton, Australia). Conditions for the RT-qPCR were a pre-
denaturing step of 95uC for 10 min, 45 cycles of; 95uC for 10 sec,
60uC for 30 sec, 72uC for 30 sec and finishing with a cooling step
at 40uC for 1 min.
The quantification cycle (Cq) for each signal was calculated
based on the Second Derivative Maximum method. A set of
serially diluted cDNAs synthesised from 3 mg of adult mouse brain
RNA was used to construct a 3-data point standard curve for every
PCR assay in each run. A PCR efficiency of between 90–110%
and an R-squared value .0.98 were used to define successful
assays. Relative quantification of target gene expression in Ts1Cje
and disomic samples was carried out using the comparative Ct
method. We performed intra-sample data normalization against 3
endogenous control reference genes Pgk1, Hmbs and Psmb2.
Differential analysis was completed with the limma package
[100] (R-script; Text S1) using empirical Bayes moderated
t-statistics which borrows information between genes [98]. P-
values were adjusted for multiple testing [99].
Neurosphere proliferation and differentiation assays
Cells from the SVZ were isolated and cultured as described
previously [56,102,103,104,105]. Briefly, avoiding white matter
and using a dissection microscope (Stermi 2000-C, Zeiss,
Oberkochen, Germany), the SVZ of the lateral walls of the lateral
ventricles were bilaterally dissected. The dissected tissue was
immersed in 2.5% pancreatin/0.5% trypsin in D-PBS (Ca
2+/
Mg
2+ free) with 200 U/ml penicillin, 200 mg/ml streptomycin for
30 min at 4uC and transferred into mouse tonicity phosphate-
buffered saline (MTPBS) for 5 min at 37uC. The pancreatin/
Figure 8. Assessment of neuroblast migration. (A) Cresyl violet
stained sections adjacent to the migration front of short-term labelled
BrdU stained neuroblasts (not shown) from a typical pair of Ts1Cje and
disomic littermate controls. Comparison of histological landmarks
highlighted a tendency of the trisomic neuroblasts to travel a shorter
distance over the 6 days than disomic neuroblasts. Original magnifi-
cation 650. Scale bar=200 mm. (B) The mean distance migrated into
the olfactory bulb by Ts1Cje neuroblasts was on average 247.5 mm
shorter than that migrated by disomic controls (P=0.056; N=3 male
and 1 female pairs of Ts1Cje and disomic littermates). (C) Neural cell
lineage schematic with the cell type examined highlighted – Nb,
neuroblast. Other cells: NSC, neural stem cell; TA, transit amplifying cell;
N, neuron; GP, glial precursor; A, astrocyte; O, oligodendrocyte.
doi:10.1371/journal.pone.0011561.g008
Ts1Cje Neurogenesis Defects
PLoS ONE | www.plosone.org 10 July 2010 | Volume 5 | Issue 7 | e11561trypsin was inhibited briefly by 2% foetal bovine serum in
MTPBS, and the tissue was mechanically dissociated. Cells were
collected by centrifugation and cultured in neural stem cell (NSC)
proliferation medium for 7 days: DMEM/F12, 5 mM HEPES,
13.4 mM NaHCO3, 0.6% D-glucose, 100 U/ml penicillin,
100 mg/ml streptomycin, 25 mg/ml insulin, 60 mM putrescine
dihydrocloride, 100 mg/ml apotransferrin, 30 nM sodium selenite,
20 nM progesterone, 10 ng/ml bovine recombinant fibroblast
growth factor 2 (FGF2), 4 mg/ml porcine heparin sodium salt,
20 ng/ml murine epidermal growth factor (EGF) and 2 mg/ml
bovine serum albumin fraction V. Under these conditions SVZ
cells proliferate and form neurospheres. Neurospheres were
collected by centrifugation and dissociated in 0.25 mg/ml trypsin,
10 mg/ml DNase I, 10 mM HEPES and 0.2 mg/ml EDTA in
Ca
2+/Mg
2+ free HBSS at 37uC for 3 min. The trypsin was
inhibited briefly by 140 mg/ml soybean trypsin inhibitor, in HEM
Figure 9. Trisomic neural progenitors form fewer neurons and more astrocytes. (A) Immunofluorescence of differentiated cells from
dissociated neurospheres stained with an anti-b-tubulin type III antibody (red) labelling neurons and bisbenzimide nuclear counterstain (blue)
(Original magnification6400; Scale bar =20 mm). (B) The number of neurons generated from Ts1Cje neurosphere cultures was reduced compared to
disomic neurosphere cultures with an average of 56% (P=3.987e-06; N=4 pairs of adult female Ts1Cje and disomic littermate controls). (C) The
number of astrocytes generated from Ts1Cje neurosphere cultures was increased compared to disomic neurosphere cultures with an average of 6%
(P=2.632e-05; N=4 pairs of adult female Ts1Cje and disomic littermate controls). (D) Neural cell lineage schematic with the cell type examined
highlighted – N, neuron; A, astrocyte; O, oligodendrocyte. Other cells: NSC, neural stem cell; TA, transit amplifying cell; Nb, neuroblast; GP, glial
precursor.
doi:10.1371/journal.pone.0011561.g009
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ornithine/laminin-coated 13 mm glass coverslips in differentiation
medium (proliferation media excluding FGF2, EGF and heparin
sodium salt with 1% bovine serum albumin fraction V) for 8 days.
Thymidine analogue treatment strategies and analysis
For assessment of neuroblast migration along the rostral
migratory stream (RMS) 4 pairs of Ts1Cje and disomic littermate
controls (3 male and 1 female pairs) were injected with 5-bromo-
29deoxyuridine (BrdU; 100 mg/g i.p.) twice daily 12 h apart for 4
days and left without treatment for 2 days. The migration front of
BrdU labelled neuroblasts was identified on serial paraffin sections
stained for BrdU. Adjacent sections were stained with cresyl violet
to reveal histological morphology. To determine the distance
migrated by the neuroblasts, the distance between the most rostral
extent of the frontal cortex, as a reference point and the migration
Figure 10. Assessment of neurite complexity. There was no difference in the number of primary neurites/cell (A) or length of primary neurite
(P=0.66) (B) between neurons differentiated from dissociated Ts1Cje and disomic neurosphere cultures (P=0.55). (C) The number of Ts1Cje neurons
with side branching was consistently reduced compared to disomic neurons. However, the difference was not statistically significant (secondary
neurite P=0.079; tertiary neurite P=0.141), (D) there was no difference in their length (secondary neurite P=0.97; tertiary neurite P=0.96). N=4 pairs
of female Ts1Cje and disomic littermate controls. (E) Neural cell lineage schematic with the cell type examined highlighted – N, neuron. Other cells:
NSC, neural stem cell; TA, transit amplifying cell; Nb, neuroblast; GP, glial precursor; A, astrocyte; O, oligodendrocyte.
doi:10.1371/journal.pone.0011561.g010
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and section thickness.
To determine the number of NSCs and progenitors and to
assess their proliferation 4 pairs of male Ts1Cje and disomic
littermate controls were injected with 5-iodo-29-deoxyuridine
(IdU; 100 mg/g i.p.) twice daily 12 h apart for 7 days, left without
treatment for 7 days and then injected with 5-chloro-29-
deoxyuridine (CldU; 100 mg/g i.p.) twice daily 12 h apart for 7
days and finally left without treatment for 7 days. The number of
CldU positive, IdU positive and double positive cells were counted
at five equally spaced rostrocaudal levels approximately 250 mm
apart ranging from the most rostral section containing fimbria of
the hippocampi to the section containing the fusion of the rhinal
fissure. Stained sections were analysed microscopically and
photographs were taken with a digital camera (Stemi 2000-C,
dissection microscope and Zeiss Axiocam HRc software Axiovi-
sion, Zeiss, Oberkochen, Germany).
Immunohistochemistry and Immunofluorescence
To ensure that assays involving cell counts were accurate, the
nuclei of cells throughout the SVZ from digital images at a
magnification of 406of 4 pairs of sex matched adult Ts1Cje and
disomic littermates were compared. The longest diameter of 630
randomly selected nuclei from each genotype were measured. We
found no significant difference in the mean length of the longest
nuclei diameter between Ts1Cje and disomic controls (data not
shown) and therefore numbers of labelled SVZ cell profiles could
be compared [106]. A general anatomical analysis of the whole
brain was completed to assess whether there are any gross
structural abnormalities in the Ts1Cje brain (for methods and
results refer to Text S1).
For thymidine analogue incorporation studies, brains were
perfusion-fixed in 4% PFA, postfixed in 4% PFA for 48 h,
embedded in paraffin and coronally sectioned at 5 mmi n
preparation for staining.
Immunohistochemistry was performed as described previously
[107] using an antibody against BrdU (M0744 Clone Bu20a; 1:10;
Dakocytomation, Glostrup, Denmark). Immunofluorescence was
performed on brain sections [108] and cells [109] as described
previously. Cells were incubated with antibodies against b-tubulin
type III (G7121; 1:2000; Promega, Madison, USA), and GFAP
(MAB3402; 1:1000; Chemicon) and sections were incubated with
antibodies against BrdU that also detects CldU but not IdU (OBT-
0030; clone BU1/75; 1:100; Accurate Chemical & Scientific
Corporation, Westbury, USA), all diluted in 10% goats serum.
Cells and sections were subsequently incubated with appropriate
fluorescently label-conjugated secondary antibodies (Molecular
Probes, Invitrogen, Carlsbad, USA; Vector laboratories, Burlin-
game, USA). An antibody against BrdU (clone B44; 1:3.5; BD
Biosciences, San Jose, USA), which also detects IdU but not CldU
was conjugated with FITC and was therefore added to the sections
with the secondary antibodies. Nuclei were counterstained with
bisBenzimide H 33258 (Sigma-AldrichH, St Louis, USA) or DAPI
(49,6-diamidino-2-phenylindole; Vector Laboratories, Burlingame,
USA). Anti-O4 (1:10; gift from T. Kilpatrick Howard Florey
Institute, Parkville, Australia) primary incubation was performed
without any prior permeabilisation.
Four pairs of sex matched (2 female, 2 male) Ts1Cje and
disomic littermate controls were assessed for the number of
apoptotic cells in the SVZ using the ApopTagH Fluorescein In Situ
Apoptosis Detection Kit S7110 according to the manufacturer’s
instructions (Chemicon International, Temecula, USA). The
number of TUNEL positive cells was counted at 5 evenly spaced
rostrocaudal intervals on sections adjacent to those assessed for
thymidine analogue incorporation.
Whole-mount immunohistochemistry was performed as de-
scribed previously [102,110] on 5 pairs of Ts1Cje and disomic
littermate controls (2 male and 3 female). Briefly, the entire lateral
walls of the lateral ventricles were dissected from perfusion-fixed
(3% PFA) brains and were immersed in cold methanol, cold
acetone, 10% goats serum, incubated with an anti-polysialic acid-
neural cell adhesion molecule (PSA-NCAM) antibody (AbC0019;
1:1000; AbCys, Paris, France) for 72 h at 4uC, and then with a
biotinylated secondary antibody for 48 h at 4uC, endogenous
peroxidase activity was quenched with 0.3% H2O2 in methanol,
and bound antibody was visualised using horseradish peroxidase-
coupled streptavidin, diaminobenzidine and H2O2. Intervening
wash steps were TBS with or without 0.5% Triton X-100.
Photographs of stained tissue were taken using a low magnification
stereomicroscope (Stemi 2000-C, Zeiss, Oberkochen, Germany)
and digital camera (AxioCam, Zeiss, Oberkochen, Germany),
PSA-NCAM-positive chains were traced and quantified using the
NIH Image analysis software, ImageJ.
Statistical analysis
StataH10 (StataCorp LP, Texas, USA) software and R language
and environment were used to perform multifactorial ANOVAs
and other statistical analyses (for further details see Text S1).
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